Drug Shortage Report for MYLAN-MIRTAZAPINE

Last updated on 2024-04-09 History
Report ID 216953
Drug Identification Number 02256118
Brand name MYLAN-MIRTAZAPINE
Common or Proper name MIRTAZAPINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) MIRTAZAPINE
Strength(s) 30MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100BT
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-01-22
Estimated end date 2024-05-07
Actual end date
Shortage status Actual shortage
Updated date 2024-04-09
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2024-04-09 French Compare
v10 2024-04-09 English Compare
v9 2024-02-28 French Compare
v8 2024-02-28 English Compare
v7 2024-02-21 French Compare
v6 2024-02-21 English Compare
v5 2024-01-30 French Compare
v4 2024-01-30 English Compare
v3 2024-01-23 English Compare
v2 2024-01-22 French Compare
v1 2024-01-22 English Compare

Showing 1 to 11 of 11